Biblioteca de Guías Clínicas sobre Cáncer

Acceso GENERAL información GUÍAS CLÍNICAS (por orden alfabético)

• AHRQ Agency Healthcare Research Quality. National Guideline Clearing House
• ASCO. American Society of Clinical Oncology- Guidelines
• BMJ Best Practice
• ClinicalKey Guías Clínicas
• ESMO. European Society for Medical Oncology
• GUíA SALUD
• GIN Guidelines International Network 
• NICE National Institute Health Care Excellence
• AHRQ Agency Healthcare Research Quality. National Guideline Clearing House
• NATIONAL COMPRENHENSIVE CANCER NETWORK (NCCN). Requiere registro gratuito para acceder.
• SIGN Scottish Intercollegiate Guidelines Network
• UpToDate 
• WHO. International Agency for Research on Cancer

 

Comité de tumores de CANCER DE MAMA

• Consenso de la Sociedad Española de Senología y Patología Mamaria (SESPM) sobre la biopsia selectiva del ganglio centinela (BSGC) y el manejo axilar en el cáncer de mama (2022) Bernet L, Piñero A, Martínez M, Vidal Sicart S, Algara M, Palomares E, Panel de Expertos de la SESPM. Rev Senol Patol Mama 2022, 35: 243-259.
• NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines)with NCCN Evidence Blocks, 2025. Requiere registro gratuito para acceder.
• SEOM-GEICAM-SOLTI clinical guidelines in advanced breast cancer (2022) Garcia-Saenz JA, Blancas I, Echavarria I, Hinojo C, Margeli M, Moreno F, Pernas S, Ramon Y Cajal T, Ribelles N, Bellet M. Clin Transl Oncol. 2023 Sep;25(9):2665-2678. doi: 10.1007/s12094-023-03203-8. Erratum in: Clin Transl Oncol. 2023 Sep. doi: 10.1007/s12094-023-03229-y. 

 

Comité de Tumores Colorectales

• 2025 Updated version v1.0 SEOM-GEMCAD-TTD clinical guidelines for the systemic treatment of metastatic colorectal cancer (2022)
• SEOM-GEMCAD-TTD clinical guidelines for the systemic treatment of metastatic colorectal cancer (2022)
• SEOM-GEMCAD-TTD clinical guidelines for the adjuvant treatment of colon cancer (2023)
• SEOM-GEMCAD-TTD clinical guidelines for localized rectal cancer (2021)
• SEOM clinical guideline on hereditary colorectal cancer (2019)
• Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
• Localised Colon Cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
• Hereditary Gastrointestinal Cancers: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
• Anal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
• Guía de práctica clínica. Diagnóstico y prevención del cáncer colorrectal. Actualización 2018
• Colorectal polypectomy and endoscopic mucosal resection: European Society of Gastrointestinal Endoscopy (ESGE) Guideline – Update 2024

 

Comité de tumores CUTÁNEOS

• Diagnosis and treatment of Merkel cell carcinoma: European consensus-based interdisciplinary guideline.Update 2022. Gauci ML, Aristei C, Becker JC, Blom A, Bataille V, Dreno B, Del Marmol V, Forsea AM, Fargnoli MC, Grob JJ, Gomes F, Hauschild A, Hoeller C, Harwood C, Kelleners-Smeets N, Kaufmann R, Lallas A, Malvehy J, Moreno-Ramirez D, Peris K, Pellacani G, Saiag P, Stratigos AJ, Vieira R, Zalaudek I, van Akkooi ACJ, Lorigan P, Garbe C, Lebbé C; European Dermatology Forum (EDF), the European Association of Dermato-Oncology (EADO) and the European Organization for Research and Treatment of Cancer (EORTC). Eur J Cancer. 2022 Aug;171:203-231. doi: 10.1016/j.ejca.2022.03.043.
• Diagnosis and Treatment of Basal Cell Carcinoma in Specialized Dermatology Units: A Clinical Practice Guideline Vílchez-Márquez F, Borregón-Nofuentes P, Barchino-Ortiz L, Ruíz-de-Casas A, Palacios-Álvarez I, Soria-Rivas A, Descalzo-Gallego MA, García-Doval I, Ríos-Buceta L, Redondo-Bellón P. Actas Dermosifiliogr (Engl Ed). 2020 May;111(4):291-299. English, Spanish. doi: 10.1016/j.ad.2019.07.006. 
• European consensus-based interdisciplinary guideline for melanoma. Part 1: Diagnostics.Update 2024. Garbe C, Amaral T, Peris K, Hauschild A, Arenberger P, Basset-Seguin N, Bastholt L, Bataille V, Brochez L, Del Marmol V, Dréno B, Eggermont AMM, Fargnoli MC, Forsea AM, Höller C, Kaufmann R, Kelleners-Smeets N, Lallas A, Lebbé C, Leiter U, Longo C, Malvehy J, Moreno-Ramirez D, Nathan P, Pellacani G, Saiag P, Stockfleth E, Stratigos AJ, Van Akkooi ACJ, Vieira R, Zalaudek I, Lorigan P, Mandala M; European Association of Dermato-Oncology (EADO), the European Dermatology Forum (EDF), and the European Organization for Research and Treatment of Cancer (EORTC). Eur J Cancer. 2025 Jan 17;215:115152. doi: 10.1016/j.ejca.2024.115152. 
• European consensus-based interdisciplinary guideline for melanoma. Part 2: Treatment Update 2025. Garbe C, Amaral T, Peris K, Hauschild A, Arenberger P, Basset-Seguin N, Bastholt L, Bataille V, Brochez L, Del Marmol V, Dréno B, Eggermont AMM, Fargnoli MC, Forsea AM, Höller C, Kaufmann R, Kelleners-Smeets N, Lallas A, Lebbé C, Leiter U, Longo C, Malvehy J, Moreno-Ramirez D, Nathan P, Pellacani G, Saiag P, Stockfleth E, Stratigos AJ, Van Akkooi ACJ, Vieira R, Zalaudek I, Lorigan P, Mandala M; European Association of Dermato-Oncology (EADO), the European Dermatology Forum (EDF), and the European Organization for Research and Treatment of Cancer (EORTC). Eur J Cancer. 2025 Jan 17;215:115153. doi: 10.1016/j.ejca.2024.115153.
• European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma. Part 1: Diagnostics and prevention-Update 2023.Stratigos AJ, Garbe C, Dessinioti C, Lebbe C, van Akkooi A, Bataille V, Bastholt L, Dreno B, Dummer R, Fargnoli MC, Forsea AM, Harwood CA, Hauschild A, Hoeller C, Kandolf-Sekulovic L, Kaufmann R, Kelleners-Smeets NW, Lallas A, Leiter U, Malvehy J, Del Marmol V, Moreno-Ramirez D, Pellacani G, Peris K, Saiag P, Tagliaferri L, Trakatelli M, Ioannides D, Vieira R, Zalaudek I, Arenberger P, Eggermont AMM, Röcken M, Grob JJ, Lorigan P; EADO, EDF, ESTRO, UEMS, EADV and EORTC. Eur J Cancer. 2023 Nov;193:113251. doi: 10.1016/j.ejca.2023.113251
• European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma: Part 2. Treatment-Update 2023.Stratigos AJ, Garbe C, Dessinioti C, Lebbe C, van Akkooi A, Bataille V, Bastholt L, Dreno B, Dummer R, Fargnoli MC, Forsea AM, Harwood CA, Hauschild A, Hoeller C, Kandolf-Sekulovic L, Kaufmann R, Kelleners-Smeets NW, Lallas A, Leiter U, Malvehy J, Del Marmol V, Moreno-Ramirez D, Pellacani G, Peris K, Saiag P, Tagliaferri L, Trakatelli M, Ioannides D, Vieira R, Zalaudek I, Arenberger P, Eggermont AMM, Röcken M, Grob JJ, Lorigan P; EADO, EDF, ESTRO, UEMS, EADV and EORTC. Eur J Cancer. 2023 Nov;193:113252. doi: 10.1016/j.ejca.2023.113252. 
• Guía de práctica clínica de melanoma de la Academia Española de Dermatología y Venereología Botella-Estrada R, Boada-García A, Carrera-Álvarez C, Fernández-Figueras M, González-Cao M, Moreno-Ramírez D, et al. Actas Dermo-Sifiliográficas. 2021;112(2):142-52. doi: 10.1016/j.ad.2020.07.003. 

Comité de Tumores Gammapatías

• Guía de Diagnóstico y tratamiento de la Amiloidosis de Cadenas Ligeras (Amiloidosis Al)
• Hematoguía MiELOMA
• EHA–EMN Evidence-Based Guidelines for diagnosis, treatment and follow-up of patients with multiple myeloma
• Guía de Mieloma Múltiple

 

Comité de tumores GINECOLÓGICOS

• AEPCC-Guía: Prevención secundaria del cancer de útero 2022. Conducta clínica ante resultados anormales de las pruebas de cribado. Coordinador: Torné A. Secretaria: del Pino M. Autores: Torné A et al.
• Nomenclatura de la Federación Internacional de Colposcopia y Patología Cervical: IFPC2011 Bornstein J et al.Obst Gynecol 2012; 120 (1): 166-172. 
• ESGO/ESTRO/ESP Guidelines for Management of patient with endometrial carcinoma Concin N et al. Int J Gynecol Cancer 2021;31:12–39.
• ESGO/ESTRO/ESP Guidelines for the management of patient with cervical cancer- Update 2023 Cibula D et al. Int J Gynecol Cancer. 2023 May 1;33(5):649-666. doi: 10.1136/ijgc-2023-004429. 
• Oncoguía SEGO: cancer de cuello uterino. Guías de práctica clínica en cancer ginecologico y mamario. Publicaciones SEGO. Octubre 2018. 
• Oncoguía SEGO: guía de recuperación intensificada en ginecología 2021 Oncoguías 
• Oncoguía SEGO: cancer escamosos invasor e vulva 2023 Oncoguías
• Oncoguía SEGO: cancer de ovario 2022. Oncoguías
• Oncoguía SEGO: cancer de endometrio 2023. Oncoguías.
• Oncoguía SEGO: sarcoma uterino 2003. Oncoguías.
• Oncoguía SEGO 

 

Comité de tumores HEMATOLÓGICOS

• SEHH Y semFYC. largos supervivientes de cancer hematológico 2024.

 

Comité de tumores HEPATOBILIOPANCREATICOS

• Ampullary Adenocarcinoma, Version 1.2023, NCCN Clinical Practice Guidelines in Oncology Chiorean EG, Chiaro MD, Tempero MA, Malafa MP, Benson AB, Cardin DB, Christensen JA, Chung V, Czito B, Dillhoff M, Donahue TR, Dotan E, Fountzilas C, Glazer ES, Hardacre J, Hawkins WG, Klute K, Ko AH, Kunstman JW, LoConte N, Lowy AM, Masood A, Moravek C, Nakakura EK, Narang AK, Nardo L, Obando J, Polanco PM, Reddy S, Reyngold M, Scaife C, Shen J, Truty MJ, Vollmer C, Wolff RA, Wolpin BM, Rn BM, Lubin S, Darlow SD. J Natl Compr Canc Netw. 2023 Jul;21(7):753-782. doi: 10.6004/jnccn.2023.0034. 
• Bile Duct Cancer (Cholangiocarcinoma) Treatment (PDQ®)–Health Professional Version 2025 National Cancer Institute.
• Biliary Tract Cancers. NCCN Guidelines 2025. Requiere registro gratuito para acceder.
• Biliary tract cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up Vogel A, Bridgewater J, Edeline J, Kelley RK, Klümpen HJ, Malka D, Primrose JN, Rimassa L, Stenzinger A, Valle JW, Ducreux M; ESMO Guidelines Committee.  Ann Oncol. 2023 Feb;34(2):127-140. doi: 10.1016/j.annonc.2022.10.506. Epub 2022 Nov 10. 
• European Neuroendocrine Tumour Society (ENETS) 2023 guidance paper for nonfunctioning pancreatic neuroendocrine tumours Kos-Kudła B, Castaño JP, Denecke T, Grande E, Kjaer A, Koumarianou A, de Mestier L, Partelli S, Perren A, Stättner S, Valle JW, Fazio N. J Neuroendocrinol. 2023 Dec;35(12):e13343. doi: 10.1111/jne.13343.
• European Neuroendocrine Tumor Society 2023 guidance paper for functioning pancreatic neuroendocrine tumour syndromes Hofland J, Falconi M, Christ E, Castaño JP, Faggiano A, Lamarca A, Perren A, Petrucci S, Prasad V, Ruszniewski P, Thirlwell C, Vullierme MP, Welin S, Bartsch DK. J Neuroendocrinol. 2023 Aug;35(8):e13318. doi: 10.1111/jne.13318. 
• European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for gastroduodenal neuroendocrine tumours (NETs) G1-G3. Panzuto F, Ramage J, Pritchard DM, van Velthuysen MF, Schrader J, Begum N, Sundin A, Falconi M, O'Toole D. J Neuroendocrinol. 2023 Aug;35(8):e13306. doi: 10.1111/jne.13306. 
• European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for digestive neuroendocrine carcinoma Sorbye H, Grande E, Pavel M, Tesselaar M, Fazio N, Reed NS, Knigge U, Christ E, Ambrosini V, Couvelard A, Tiensuu Janson E. J Neuroendocrinol. 2023 Mar;35(3):e13249. doi: 10.1111/jne.13249. 

• Gallbladder Cancer Treatment. National Cancer Institute

• Gastroenteropancreatic neuroendocrine neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Pavel M, Öberg K, Falconi M, Krenning EP, Sundin A, Perren A, Berruti A; ESMO Guidelines Committee. Ann Oncol. 2020 Jul;31(7):844-860. doi: 10.1016/j.annonc.2020.03.304.

• Hepatocellular Carcinoma. NCCN Guidelines 2025. Requiere registro gratuito para acceder.
• Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.Vogel A, Cervantes A, Chau I, Daniele B, Llovet JM, Meyer T, Nault JC, Neumann U, Ricke J, Sangro B, Schirmacher P, Verslype C, Zech CJ, Arnold D, Martinelli E; ESMO Guidelines Committee.Ann Oncol. 2018 Oct 1;29(Suppl 4):iv238-iv255. doi: 10.1093/annonc/mdy308. Erratum in: Ann Oncol. 2019 May 1;30(5):871-873. doi: 10.1093/annonc/mdy510. Erratum in: Ann Oncol. 2022 Jun;33(6):666. doi: 10.1016/j.annonc.2022.03.009.
• Neuroendocrine and Adrenal Tumors, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. Shah MH, Goldner WS, Benson AB, Bergsland E, Blaszkowsky LS, Brock P, Chan J, Das S, Dickson PV, Fanta P, Giordano T, Halfdanarson TR, Halperin D, He J, Heaney A, Heslin MJ, Kandeel F, Kardan A, Khan SA, Kuvshinoff BW, Lieu C, Miller K, Pillarisetty VG, Reidy D, Salgado SA, Shaheen S, Soares HP, Soulen MC, Strosberg JR, Sussman CR, Trikalinos NA, Uboha NA, Vijayvergia N, Wong T, Lynn B, Hochstetler C. J Natl Compr Canc Netw. 2021 Jul 28;19(7):839-868. doi: 10.6004/jnccn.2021.0032. 
• Pancreatic Adenocarcinoma, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. Tempero MA, Malafa MP, Al-Hawary M, Behrman SW, Benson AB, Cardin DB, Chiorean EG, Chung V, Czito B, Del Chiaro M, Dillhoff M, Donahue TR, Dotan E, Ferrone CR, Fountzilas C, Hardacre J, Hawkins WG, Klute K, Ko AH, Kunstman JW, LoConte N, Lowy AM, Moravek C, Nakakura EK, Narang AK, Obando J, Polanco PM, Reddy S, Reyngold M, Scaife C, Shen J, Vollmer C, Wolff RA, Wolpin BM, Lynn B, George GV. J Natl Compr Canc Netw. 2021 Apr 1;19(4):439-457. doi: 10.6004/jnccn.2021.0017. 
• Pancreatic Cancer—Health Professional Version. 2025 National Cancer Institute.
• Pancreatic cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Conroy T, Pfeiffer P, Vilgrain V, Lamarca A, Seufferlein T, O'Reilly EM, Hackert T, Golan T, Prager G, Haustermans K, Vogel A, Ducreux M; ESMO Guidelines Committee. . Ann Oncol. 2023 Nov;34(11):987-1002. doi: 10.1016/j.annonc.2023.08.009.

• Pancreatic Neuroendocrine Tumors (Islet Cell Tumors) Treatment. National Cancer Institute.

• Primary Liver Cancer Treatment. Health professional Version. National Cancer Institute 2025.

 

Comité de tumores MAXILOFACIAL

• Comisión de cancer de cabeza y cuello. Protocolo de cáncer de cabeza y cuello  (Hospital Universitario Reina Sofia)
• EANM Guidelines (Repositorio).
• ESMO Clinical Practice Guidelines: head and neck cancers.
• ESTRO Guidelines.
• ESUR Guidelines on contrast Agents.
• Diagnosis and Management of Squamous Cell Carcinoma of Unknown Primary in the Head and Neck: ASCO Guideline Maghami E, Ismaila N, Alvarez A, Chernock R, Duvvuri U, Geiger J, Gross N, Haughey B, Paul D, Rodriguez C, Sher D, Stambuk HE, Waldron J, Witek M, Caudell J.J Clin Oncol. 2020 Aug 1;38(22):2570-2596. doi: 10.1200/JCO.20.00275. 
• Immunotherapyandbiomarker testing in recurren and metastatic head and neck cancers: ASCO guideline. Yilmaz E, Ismaila N, Bauman JE, Dabney R, Gan G, Jordan R, Kaufman M, Kirtane K, McBride SM, Old MO, Rooper L, Saba NF, Sheth S, Subramaniam RM, Wise-Draper TM, Wong D, Mell LK.  J Clin Oncol. 2023 Feb 10;41(5):1132-1146. doi: 10.1200/JCO.22.02328.
• Management of the neck in squamous cell carcinoma of the oral cavity and oropharynx: ASCO clinical practice guideline Koyfman SA, Ismaila N, Crook D, D'Cruz A, Rodriguez CP, Sher DJ, Silbermins D, Sturgis EM, Tsue TT, Weiss J, Yom SS, Holsinger FC.. J Clin Oncol. 2019 Jul 10;37(20):1753-1774. doi: 10.1200/JCO.18.01921.
• Management of salivary gland malignancy: ASCO Guideline Geiger JL, Ismaila N, Beadle B, Caudell JJ, Chau N, Deschler D, Glastonbury C, Kaufman M, Lamarre E, Lau HY, Licitra L, Moore MG, Rodriguez C, Roshal A, Seethala R, Swiecicki P, Ha P. J Clin Oncol. 2021 Jun 10;39(17):1909-1941. doi: 10.1200/JCO.21.00449.
• Squamous cell carcinoma of the oral cavity, larynx, oropharynx and hypopharynx: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up  Machiels JP, René Leemans C, Golusinski W, Grau C, Licitra L, Gregoire V; EHNS Executive Board. Ann Oncol. 2020 Nov;31(11):1462-1475. doi: 10.1016/j.annonc.2020.07.011.

 

Comité de Tumores Neoplasias Mieloides y Leucemias Agudas

• Guías españolas de SMD y LMMC  

Comité de tumores SISTEMA NERVIOSO CENTRAL

• Guía clínica SEOM-GEINO de gliomas de alto grado 2022.
• Guía clínica SEOM-GEINO de gliomas de bajo grado 2023.

 

Comité de tumores OFTALMOLOGÍA

• Guía de Melanoma Uveal. Guías de  práctiva clínica de la SERV (Sociedad Española de Retina y Vítreo), 2016. Coordinadores: Maria José Blanco Teijeiro y Antonio Piñeiro Ces. 

 

Comité de tumores OTORRINOLARINGOLOGIA

• ESMO Clinical Practice Guidelines: Head and Neck Cancers. European Society for Medical Oncology.

• Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology.Pfister DG, Spencer S, Adelstein D, Adkins D, Anzai Y, Brizel DM, Bruce JY, Busse PM, Caudell JJ, Cmelak AJ, Colevas AD, Eisele DW, Fenton M, Foote RL, Galloway T, Gillison ML, Haddad RI, Hicks WL, Hitchcock YJ, Jimeno A, Leizman D, Maghami E, Mell LK, Mittal BB, Pinto HA, Ridge JA, Rocco JW, Rodriguez CP, Shah JP, Weber RS, Weinstein G, Witek M, Worden F, Yom SS, Zhen W, Burns JL, Darlow SD.J Natl Compr Canc Netw. 2020 Jul;18(7):873-898. doi: 10.6004/jnccn.2020.0031.
• SEOM clinical guidelines for the treatment of head and neck cancer (2020). Mesia R, Iglesias L, Lambea J, Martínez-Trufero J, Soria A, Taberna M, Trigo J, Chaves M, García-Castaño A, Cruz J. Clin Transl Oncol. 2021 May;23(5):913-921. doi: 10.1007/s12094-020-02533-1. Epub 2021 Feb 26. Erratum in: Clin Transl Oncol. 2021 May;23(5):1001. doi: 10.1007/s12094-021-02582-0. 

 

Comité de tumores de TIROIDES

• 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, Pacini F, Randolph GW, Sawka AM, Schlumberger M, Schuff KG, Sherman SI, Sosa JA, Steward DL, Tuttle RM, Wartofsky L.Thyroid. 2016 Jan;26(1):1-133. doi: 10.1089/thy.2015.0020.
• American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer. Bible KC, Kebebew E, Brierley J, Brito JP, Cabanillas ME, Clark TJ Jr, Di Cristofano A, Foote R, Giordano T, Kasperbauer J, Newbold K, Nikiforov YE, Randolph G, Rosenthal MS, Sawka AM, Shah M, Shaha A, Smallridge R, Wong-Clark CK. 2021 Thyroid. 2021 Mar;31(3):337-386. doi: 10.1089/thy.2020.0944. Erratum in: Thyroid. 2021 Oct;31(10):1606-1607. doi: 10.1089/thy.2020.0944.correx. 
• NCCN Clinical  Practice Guidelines in Oncology: Thyroid Cancer. National Comprehensive Cancer Network. 2024. Requiere registro gratuito para acceder.
• Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma. TWells SA Jr, Asa SL, Dralle H, Elisei R, Evans DB, Gagel RF, Lee N, Machens A, Moley JF, Pacini F, Raue F, Frank-Raue K, Robinson B, Rosenthal MS, Santoro M, Schlumberger M, Shah M, Waguespack SG; American Thyroid Association Guidelines Task Force on Medullary Thyroid Carcinoma.hyroid. 2015 Jun;25(6):567-610. doi: 10.1089/thy.2014.0335. 
• NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) Thyroid Carcinoma

 

Comité de tumores de TORÁCICOS

• Early and locally advanced non-small-cell lung cancer: an update of the ESMO Clinical Practice Guidelines focusing on diagnosis, staging, systemic and local therapy. Remon J, Soria JC, Peters S; ESMO Guidelines Committee. Ann Oncol. 2021 Dec;32(12):1637-1642. doi: 10.1016/j.annonc.2021.08.1994.
• ERS/ESTS/ESTRO/ESR/ESTI/EFOMP statement on management of incidental findings from low dose CT screening for lung cancer.O'Dowd EL, Tietzova I, Bartlett E, Devaraj A, Biederer J, Brambilla M, Brunelli A, Chorostowska-Wynimko J, Decaluwe H, Deruysscher D, De Wever W, Donoghue M, Fabre A, Gaga M, van Geffen W, Hardavella G, Kauczor HU, Kerpel-Fronius A, van Meerbeeck J, Nagavci B, Nestle U, Novoa N, Prosch H, Prokop M, Putora PM, Rawlinson J, Revel MP, Snoeckx A, Veronesi G, Vliegenthart R, Weckbach S, Blum TG, Baldwin DR. Eur Respir J. 2023 Oct 19;62(4):2300533. doi: 10.1183/13993003.00533-2023. Erratum in: Eur Respir J. 2024 Feb 1;63(2):2350533. doi: 10.1183/13993003.50533-2023.
• Non-oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Hendriks LE, Kerr KM, Menis J, Mok TS, Nestle U, Passaro A, Peters S, Planchard D, Smit EF, Solomon BJ, Veronesi G, Reck M; ESMO Guidelines Committee. Ann Oncol. 2023 Apr;34(4):358-376. doi: 10.1016/j.annonc.2022.12.013.
• Non-Small Cell Lung Cancer. 2025.NCCN Guidelines.Requiere registro gratuito para acceder.
• Oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment andfollow-up. Hendriks LE, Kerr KM, Menis J, Mok TS, Nestle U, Passaro A, Peters S, Planchard D, Smit EF, Solomon BJ, Veronesi G, Reck M; ESMO Guidelines Committee. Ann Oncol. 2023 Apr;34(4):339-357. doi: 10.1016/j.annonc.2022.12.009. 
• Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.Dingemans AC, Früh M, Ardizzoni A, Besse B, Faivre-Finn C, Hendriks LE, Lantuejoul S, Peters S, Reguart N, Rudin CM, De Ruysscher D, Van Schil PE, Vansteenkiste J, Reck M; ESMO Guidelines Committee.  Ann Oncol. 2021 Jul;32(7):839-853. doi: 10.1016/j.annonc.2021.03.207. 
• Small Cell Lung Cancer. NCCN Guidelines. Requiere registro gratuito para acceder.
• Spanish Society of Thoracic Surgery (SECT) consensus document. Long-term follow-up for operated patients with lung cancer Cilleruelo Ramos Á, Figueroa Almánzar S, López Castro R, Martínez Hernández NJ, Mezquita Pérez L, Moreno Casado P, Zabaleta Jiménez J. Cir Esp (Engl Ed). 2022 Jun;100(6):320-328. doi: 10.1016/j.cireng.2022.05.024. Epub 2022 May 25. PMID: 35643357.